UK cultivated meat company Meatly has secured £10.4 million in new funding to help build what is set to become Europe’s largest cultivated meat production facility.
The London-based business made headlines in 2024 as the first company in Europe to gain approval to sell cultivated meat commercially, before launching a retail trial with Pets at Home in 2025.
The new investment will support the development of a 20,000-litre pilot bioreactor facility in London, allowing Meatly to scale up continuous production of cultivated chicken for the UK pet food market. Product releases from the site are expected in 2027.
The funding round includes backing from Oyster Bay Venture Capital, Clean Growth Fund and JamJar Investments, alongside existing investors Agronomics and Pets at Home.
Meatly chief executive Owen Ensor said the investment represents a major milestone for both the company and the UK’s growing food technology sector, adding that the business is now ready to demonstrate cultivated meat production at commercial scale.
Investors say cultivated protein could play an important role in reducing the environmental impact of meat production, while still producing real animal protein for consumers and pets.
